UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT - DE 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:600-700
Total Number of Projects:> 1000
Networking Rank (Reputation):600-700

Ranking timeline:

Project Participation Performance(2018-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 21
As coordinator: 2
As participant: 17
Sole participant: 2
Coordinator / Participant Ratio: 0.12*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 0 10.714.678 1.395.050 2
2022 1.768.583 1.446.071 1.874.021 1 1
2021 8.728.185 28.294.033 3.063.160 1 5
2020 150.000 28.767.808 1.760.070 1 4
2019 0 22.532.675 1.571.001 3
2018 6.097.875 6.752.251 2.798.899 1 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V5
UNIVERSIDAD DE NAVARRA4
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL3
JANSSEN PHARMACEUTICA NV3
KAROLINSKA INSTITUTE3
KATHOLIEKE UNIVERSITEIT LEUVEN3
NOVARTIS PHARMA3
TCURX3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD3
ACADEMISCH ZIEKENHUIS GRONINGEN2
ATOS ORIGIN INTEGRATION SAS2
BAYER2
BIOSCI CONSULTING BVBA2
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG2
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
F HOFFMANNLA ROCHE2
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA2
HOSPITAL CLINIC DE BARCELONA2
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
LEIDS UNIVERSITAIR MEDISCH CENTRUM2
MEDIZINISCHE UNIVERSITAT INNSBRUCK2
MERCK SHARP & DOHME CORP2
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS2
NOVO NORDISK2
OSPEDALE PEDIATRICO BAMBINO GESU2
PFIZER LIMITED2
SANOFIAVENTIS2
STICHTING VUMC2
THE PROVOST FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN HEREINAFTER TRINITY COLLEGE DUBLIN2
UNIVERSITAETSKLINIKUM JENA2
UNIVERSITY COLLEGE LONDON2
UPPSALA UNIVERSITET2
ABBVIE INC1
ACADEMIC MEDICAL CENTRE AMSTERDAM1
ACCELOPMENT SCHWEIZ1
AE MEDICALIS BV1
AGLARIS CELL SL1
AGLARIS LIMITED1
ALACRIS THERANOSTICS1
ARTEEVO TECHNOLOGIES1
ARTEMIS BIOSUPPORT BV1
ARTTIC1
ARTTIC INNOVATION1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASTELLAS PHARMA EUROPE BV1
ASTRAZENECA1
AUSTRIAN RESEARCH CENTERS SIEBERDORF1
AZIENDA SOCIOSANITARIA TERRITORIALE FATEBENEFRATELLI SACCO1
BIOGAZELLE1
BIONORICA RESEARCH1
BLUEBIRD BIO INC1
BOSTON SCIENTIFIC LIMITED1
CELGENE MANAGEMENT SARL1
CELLIX LIMITED1
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS1
CENTRO HOSPITALAR E UNIVERSITARIO DE COIMBRA EPE1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CIAOTECH1
COFAC COOPERATIVA DE FORMACAO E ANIMACAO CULTURAL CRL1
COVANCE LABORATORIES1
DIMOKRITIO PANEPISTIMIO THRAKIS1
DRKBLUTSPENDEDIENST BADENWURTTEMBERGHESSEN GGMBH1
DYNAMIC421
EBERS MEDICAL TECHNOLOGY SL1
ECOLE NORMALE SUPERIEURE1
EINDHOVEN UNIVERSITY OF TECHNOLOGY1
EKON MODELING SOFWARE SYSTEMS LTDEKON1
ELI LILLY AND COMPANY LIMITED1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
ERASMUS UNIVERSITEIT ROTTERDAM1
EREVNITIKO PANEPISTIMIAKO INSTITOUTO SYSTIMATON EPIKOINONION KAI YPOLGISTONEMP1
EREVNITIKO PANEPISTIMIAKO INSTITUTOMELETIS KE ANTIMETOPISIS GENETIKONKE KAKOETHON NOSIMATON TIS PEDIKISILIKIAS1
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS1
EUROPEAN CANCER PATIENT COALITION1
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE1
EUROPEAN HEMATOLOGY ASSOCIATION1
EUROPEAN MOLECULAR BIOLOGY LABORATORY1
EUROPEAN SOCIETY OF ANAESTHESIOLOGY AND INTENSIVE CARE AISBL1
EXCELYA HUNGARY KORLATOLT FELELOSSEGU TARSASAG1
F4PHARMA GES M B H1
FORUM DES PATIENTS EUROPEENS1
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS1
FUJIFILM CELLULAR DYNAMICS INC1
FUJIFILM EUROPE BV1
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE1
FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA1
FUNDACIO PRIVADA INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU1
FUNDACION PARA LA INVESTIGACION BIOSANITARIA DE ANDALUCIA ORIENTALALEJANDRO OTERO1
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT1
GOTTFRIED WILHELM LEIBNIZ UNIVERSITAET HANNOVER1
H LUNDBECK AS1
HOSPITAL DO ESPIRITO SANTO DE EVORA EPE1
HYD RAKKUTATO ES GYOGYSZERFEJLESZTO KFT1
IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON1
IMPRENSA NACIONAL CASA DA MOEDA S A1
INOCURE SRO1
INSERM TRANSFERT1
INSTITUT CATALA DE LA SALUT1

Constancy:

Total number of partners: 260
Partner loyalty:
Frequent Partner: (> 2 projects): 30
Rare Partner: 230
Frequent / Rare Partner Ratio: 0.13

Project overview:

Start dateProjectacronymrolefundingpartners
2023-01-01The health benefits of deuterium depletion on synaptic function, regional metabolism, and behaviour Aqua-Synapseparticipant763.6006
2023-01-01Elucidation of risk factors and health determinants associated with PROGRESSION of Monoclonal Gammopathies to Multiple Myeloma ELMUMYparticipant9.951.07814
2022-10-01CONSOLIDATING THE EXPERTISE OF NECMETTIN ERBAKAN UNIVERSITY TOWARDS THE DEVELOPMENT OF BIOFIBERS FOR WOUND HEALING AND TISSUE REGENERATION REGENEUparticipant1.446.0715
2022-06-01Dissecting the impact of epithelial stem cell niches on oral cancer heterogeneity OralNichecoordinator1.768.5831
2021-08-01Biomarker and AI-supported FX06 therapy to prevent progression from mild and moderate to severe stages of COVID-19 COVendparticipant9.994.97818
2021-06-01Cerebellum and Emotional Networks CENparticipant4.121.9138
2021-05-01Design and manufacture of sustainable materials for additive manufacturing technologies DeMANSparticipant303.6007
2021-01-01Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy T2EVOLVEcoordinator8.728.18529
2021-01-01Serotonin and BEYOND: Brain development research Excelling Young Ones in Neurotechnologies and Discoveries SEROTONIN and BEYONDparticipant4.012.55112
2021-01-01Artificial Intelligence-driven, Decentralized Production for Advanced Therapies in the Hospital AIDPATHparticipant9.860.99215
2020-03-01Disposable well-plate inserts and perfusion chambers for easy-to-use and generic microchannel creation in 3D tissue culture Design2Flowcoordinator150.0001
2020-01-01Associative mechanisms linking a defective minipuberty to the appearance of mental and nonmental disorders: infantile NO replenishment as a new therapeutic possibility miniNOparticipant6.487.77012
2020-01-01Unification of treatments and Interventions for Tinnitus patients UNITIparticipant5.989.34414
2020-01-01PharmaLedger PharmaLedgerparticipant8.290.69430
2020-01-01Computational biomechanics and bioengineering 3D printing to develop a personalized regenerative biological ventricular assist device to provide lasting functional support to damaged hearts BRAV3participant8.000.00017
2019-12-01Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies imSAVARparticipant10.999.31628
2019-01-01Immune DIREcted and Cancer-selective immunoTherapy I-DireCTparticipant2.533.3585
2019-01-01Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain IM2PACTparticipant9.000.00027
2018-08-01Targeting neuroinflammation to combat pathological pain in neurodegenerative diseases and chronic pain syndromes TOBeATPAINparticipant2.870.3598
2018-01-01TArgeting Platelet Adhesion receptors in thrombosiS TAPASparticipant3.881.89213
2018-01-01SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma – a rare hematologic disease CARAMBAcoordinator6.097.87511